Shares of Silverback Therapeutics, Inc. (NASDAQ:SBTX – Get Free Report) dropped 2.8% during mid-day trading on Wednesday . The company traded as low as $8.16 and last traded at $8.26. Approximately 334,673 shares traded hands during mid-day trading, a decline of 1% from the average daily volume of 337,931 shares. The stock had previously closed at $8.50.
Silverback Therapeutics Trading Up 3.2 %
The firm has a market cap of $301.08 million, a PE ratio of -3.45 and a beta of 0.60. The stock has a 50 day simple moving average of $8.84 and a 200-day simple moving average of $6.40.
Silverback Therapeutics Company Profile
Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.
Recommended Stories
- Five stocks we like better than Silverback Therapeutics
- Financial Services Stocks Investing
- 3 Stocks Leading the U.S. Agriculture Comeback
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Dividend Capture Strategy: What You Need to Know
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Silverback Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silverback Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
